459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation

M. Patel; J-S Lee; M.J. Miguel; T. Burns; A. Gonzalez; T.W. Kim; Matthew Krebs; Hans Prenen; E. Shmueli; Jayal Desai; Patricia Lorusso; A. Sacher; Y. Choi; N. Dharia; M.T. Lin; S. Mandlekar; S. Royer-Joo; J.L. Schutzman; E. Garralda

doi:10.1016/j.annonc.2022.07.588

459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation

M. Patel, J-S Lee, M.J. Miguel, T. Burns, A. Gonzalez, T.W. Kim, Matthew Krebs, Hans Prenen, E. Shmueli, Jayal Desai, Patricia Lorusso, A. Sacher, Y. Choi, N. Dharia, M.T. Lin, S. Mandlekar, S. Royer-Joo, J.L. Schutzman, E. Garralda

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S749
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.07.588
Publication status	Published - 1 Sept 2022

Access to Document

10.1016/j.annonc.2022.07.588

Cite this

Patel, M., Lee, J.-S., Miguel, M. J., Burns, T., Gonzalez, A., Kim, T. W., Krebs, M., Prenen, H., Shmueli, E., Desai, J., Lorusso, P., Sacher, A., Choi, Y., Dharia, N., Lin, M. T., Mandlekar, S., Royer-Joo, S., Schutzman, J. L., & Garralda, E. (2022). 459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation. Annals of Oncology, 33, S749. https://doi.org/10.1016/j.annonc.2022.07.588

@article{3b864392fac349ee9050f9fd252364ae,

title = "459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation",

author = "M. Patel and J-S Lee and M.J. Miguel and T. Burns and A. Gonzalez and T.W. Kim and Matthew Krebs and Hans Prenen and E. Shmueli and Jayal Desai and Patricia Lorusso and A. Sacher and Y. Choi and N. Dharia and M.T. Lin and S. Mandlekar and S. Royer-Joo and J.L. Schutzman and E. Garralda",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.annonc.2022.07.588",

language = "English",

volume = "33",

pages = "S749",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Patel, M, Lee, J-S, Miguel, MJ, Burns, T, Gonzalez, A, Kim, TW, Krebs, M, Prenen, H, Shmueli, E, Desai, J, Lorusso, P, Sacher, A, Choi, Y, Dharia, N, Lin, MT, Mandlekar, S, Royer-Joo, S, Schutzman, JL & Garralda, E 2022, '459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation', Annals of Oncology, vol. 33, pp. S749. https://doi.org/10.1016/j.annonc.2022.07.588

TY - JOUR

T1 - 459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation

AU - Patel, M.

AU - Lee, J-S

AU - Miguel, M.J.

AU - Burns, T.

AU - Gonzalez, A.

AU - Kim, T.W.

AU - Krebs, Matthew

AU - Prenen, Hans

AU - Shmueli, E.

AU - Desai, Jayal

AU - Lorusso, Patricia

AU - Sacher, A.

AU - Choi, Y.

AU - Dharia, N.

AU - Lin, M.T.

AU - Mandlekar, S.

AU - Royer-Joo, S.

AU - Schutzman, J.L.

AU - Garralda, E.

PY - 2022/9/1

Y1 - 2022/9/1

U2 - 10.1016/j.annonc.2022.07.588

DO - 10.1016/j.annonc.2022.07.588

M3 - Meeting Abstract

SN - 0923-7534

VL - 33

SP - S749

JO - Annals of Oncology

JF - Annals of Oncology

ER -